Close

Swissmedic Validates Orchard Therapeutics' s Marketing Application For Libmeldy

Published on December 01, 2022 12:11 PM GMT

Swissmedic Validates Orchard Therapeutics' s Marketing Application For Libmeldy — Image source: ©2022 Kalkine Media®

Dec 1 (Reuters) - Orchard Therapeutics PLC:

* ORCHARD THERAPEUTICS ANNOUNCES SWISSMEDIC VALIDATION OF MARKETING AUTHORIZATION APPLICATION FOR LIBMELDY (ATIDARSAGENE AUTOTEMCEL)

* ORCHARD THERAPEUTICS PLC - COMPANY EXPECTS TO RECEIVE SWISSMEDIC'S ASSESSMENT REPORT IN FIRST HALF OF 2023 Source text for Eikon: Further company coverage:

Reuters

Reuters -
90245 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.